Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

Capsule – 18/11: SBI Mutual Fund stakes up Manpasand Beverages, El Dorado Biotech dumps Onelife Cap Advisors


We are starting a new “Capsule” series which will come to you on a regular basis, of data that is revealed in the markets but needs to be collated, cleaned and filtered to make tradeable sense. We’d love your feedback.

Here is a summary of Bulk & Block Deal transactions in this week. A Bulk Deal is a trade, where total quantity bought or sold is more than 0.5% of the number of equity shares of the company. A trade, with a minimum quantity of 5,00,000 shares or minimum value of Rs.5 crore executed through a single transaction on this separate window of the stock exchange will constitute a Block Deal.

The snapshot below excludes the Intra Day Trade, Promoter Exchange and Deals which are not significant in terms of Stock price or Deal value.

(Click here for the Bulk/Block Deals for 17-Nov-15 and Bulk/Block Deals for 16-Nov-15)

SBI Mutual Fund, El Dorado Biotech, Clearwater Capital Partners, Dikson Trading & Finance Company, Dikson Trading & Finance Company, Solutions Finquest Financial, GHI LTP, Hypnos Fund, Nalanda India Fund

Manpasand Beverages

Background: A fruit drink manufacturing company with a primary focus on mango fruit, which is the leading flavour for juice drinks in India. It owns brands such as MangoSip, Fruits Up, Manpasand ORS, and Pure Sip. Its MangoSip brand was the 2nd largest selling mango drink in India in 2014.

SBI Mutual Fund which held 2,498,121 shares or 4.99% as of September, 2015 today increased its market share by purchasing 3,55,000 shares or 0.71% from the open market at an average price of Rs. 370/-.

With this purchase its new stake stands at 2,853,121 shares or 5.70% making it the second largest investor behind SAIF Partners which owns 11,186,000 shares or 22.35%. Other investors include Goldman Sachs India Fund +4.99%, Aditya Birla Private Equity Trust +2.79%, ICICI Prudential Balanced Advantage Fund +2.25%, Birla Sun Life Insurance Company +1.31%, and DNB Fund +1.04%.

News: Manpasand Beverages plans to build new plant at Ambala

Net Profit, EPS, Revenue,Manpasand Beverages

Onelife Cap Advisors

Background: Onelife together is an investment group specialized in investing in companies offering high growth opportunities. Onelife Capital Advisors Ltd offers strategic advisory services to Corporates, HNIs, and Family Offices.

El Dorado Biotech which held 152,549 shares or 1.14% as of June, 2015 today sold 82,315 shares or 0.61% in the open market at an average price of Rs. 56.57/-. El Dorado Biotech had also made an open market purchase of 100,000 shares or 0.75% at an average price of Rs. 64.50/- on 14-Oct-15.

News: None

ResultsNet Profit, EPS, Revenue, Onelife Cap Advisors

Delivery Volume Shockers!

We have compiled a list of those stocks which have seen massive increases in the “deliverable quantity to traded quantity %”.

Stocks are traded every day and most stocks see intraday trading (buy and sell on the same day). Intraday trades don’t result in delivery – if a two people buy and sell from each other and square off within the day, there will be volume, but no actual shares will change hands.

Delivery volumes as a percentage of total volume shows us how much of the stock is traded versus held for more than a day. It’s not very useful to use this data to trade per se.

But what is useful is if the delivery percentage JUMPS. If a stock is thinly delivered (say 30% delivery) and jumps up to 80% delivery then we are likely to be seeing some action in that stock because either a big buyer is in or a big seller is.

Listed below, are the Top 25 for today (18th Nov 2015):

Trading Volumes_18Nov

Subscribe to Capital Mind:

To subscribe to new posts by email, once a day, delivered to your Inbox:

[wysija_form id=”1″]


Also, do check out Capital Mind Premium, where we provide high
quality analysis on macro, fixed income and stocks. Also see our
portfolio which has given stellar returns in our year, trade by trade
as we progress. Take a 30-day trial:

[wysija_form id=”2″]


dividerNext Gen Financial Analytics


Like our content? Join Capitalmind Premium.

  • Equity, fixed income, macro and personal finance research
  • Model equity and fixed-income portfolios
  • Exclusive apps, tutorials, and member community
Subscribe Now Or start with a free-trial